NEW YORK, April 6 (GenomeWeb News) - The Canary Foundation has given CA$1 million ($860,000) to the British Columbia Cancer Foundation to develop a blood test for the early detection of ovarian cancer, the organization said yesterday.
The funding will be used by the BC Cancer Agency on Vancouver Island as part of a collaborative research project involving multiple institutions.
According to Don Listwin, founder of the Canary Foundation, Michael Ball, CEO of proteomics software company GenoLogics was "instrumental" in encouraging the donation. "Initially, a common vision for the future of early cancer detection using proteomics research connected us," Listwin said in a statement.
Besides the BC Cancer Agency, the project involves researchers from the Fred Hutchinson Cancer Research Center; Stanford University; the University of Southern California; the University of California, San Francisco; and Intel.